Zhengzhou Principle Biotechnology Co., Ltd. was established in 2009. It is one of the high-quality CDMO companies in the Central Plains region, focusing on the fields of chemical drugs and new materials. It has now developed into a specialized new small giant enterprise integrating scientific research, high-end customization, technical services and transformation, production, and international trade.
The company currently has more than 160 employees, of which more than 70% are R&D and technology transformation teams led by doctors and senior engineers. It has a R&D center of more than 4,000 square meters and an industrial transformation base of 120 acres.
Under the leadership of the core founder Mr. Wu Xiaojun, after years of painstaking research, the company has formed two core series of products, acridine series and borane series, and established the "Henan Acridine Compounds Engineering Technology Research Center" and "Zhengzhou Carbon Borane Synthesis Engineering Technology Research Center", multiple projects have broken through technical barriers, more than 20 products have achieved industrial transformation (many results have been rated as domestic leading technologies), and more than 70 countries, more than 70 universities and research institutions at home and abroad The organization has product or technical cooperation.
The company's core feature is "the transformation of laboratory technology into large-scale production technology"; the core product is "standard operating procedures for the industrial production of target products!"
Currently, 54 patents have been applied for, including 49 national invention patents and 27 have been authorized.